Vanitha Ramakrishnan

4.4k total citations · 1 hit paper
32 papers, 2.8k citations indexed

About

Vanitha Ramakrishnan is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Vanitha Ramakrishnan has authored 32 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 10 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Vanitha Ramakrishnan's work include Platelet Disorders and Treatments (10 papers), Cell Adhesion Molecules Research (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Vanitha Ramakrishnan is often cited by papers focused on Platelet Disorders and Treatments (10 papers), Cell Adhesion Molecules Research (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Vanitha Ramakrishnan collaborates with scholars based in United States, Australia and United Kingdom. Vanitha Ramakrishnan's co-authors include Johan Sundelin, Sverker Nystedt, Alan T. Nurden, Ruey‐Bing Yang, Laura England, Paquita Nurden, D Vincent, Gunther Hollopeter, David Julius and Pamela B. Conley and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Vanitha Ramakrishnan

31 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of the platelet ADP receptor targeted by antithrombotic drugs

2001 1.1k citations Gunther Hollopeter, Hans‐Michael Jantzen et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vanitha Ramakrishnan United States	17	899	784	689	500	446	32	2.8k
Françoise Bono France	29	403 0.4×	1.3k 1.7×	341 0.5×	380 0.8×	69 0.2×	65	2.7k
Ivo Cornelissen United States	21	607 0.7×	1.8k 2.3×	264 0.4×	389 0.8×	33 0.1×	28	3.0k
Takashi Murate Japan	32	944 1.1×	2.0k 2.5×	221 0.3×	527 1.1×	46 0.1×	137	3.5k
Hitoshi Takagi Japan	28	131 0.1×	2.2k 2.8×	502 0.7×	342 0.7×	88 0.2×	43	3.8k
Markus Bender Germany	23	1.1k 1.2×	424 0.5×	441 0.6×	196 0.4×	26 0.1×	51	2.1k
Wolfgang Bergmeier United States	19	1.6k 1.7×	354 0.5×	570 0.8×	139 0.3×	25 0.1×	23	2.2k
Olivier Peyruchaud France	29	511 0.6×	1.9k 2.5×	74 0.1×	1.7k 3.3×	112 0.3×	76	3.8k
Boris Strilić Germany	20	128 0.1×	1.5k 1.9×	131 0.2×	861 1.7×	130 0.3×	24	2.8k
Götz Münch Germany	26	732 0.8×	686 0.9×	1.2k 1.8×	169 0.3×	33 0.1×	66	2.2k
Gene Liau United States	29	175 0.2×	2.3k 3.0×	272 0.4×	259 0.5×	36 0.1×	60	3.6k

Countries citing papers authored by Vanitha Ramakrishnan

Since Specialization

Citations

This map shows the geographic impact of Vanitha Ramakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanitha Ramakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanitha Ramakrishnan more than expected).

Fields of papers citing papers by Vanitha Ramakrishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanitha Ramakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanitha Ramakrishnan. The network helps show where Vanitha Ramakrishnan may publish in the future.

Co-authorship network of co-authors of Vanitha Ramakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Vanitha Ramakrishnan. A scholar is included among the top collaborators of Vanitha Ramakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanitha Ramakrishnan. Vanitha Ramakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, Jennifer R., Jessica Li, Barbara Eichhorst, et al.. (2023). Acquired Mutations in Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study. Blood. 142(Supplement 1). 1890–1890. 11 indexed citations

Tedeschi, Alessandra, Emmanuelle Ferrant, Ian W. Flinn, et al.. (2021). Zanubrutinib in Combination with Venetoclax for Patients with Treatment-Naïve (TN) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) with del(17p): Early Results from Arm D of the SEQUOIA (BGB-3111-304) Trial. Blood. 138(Supplement 1). 67–67. 23 indexed citations

Patnaik, Amita, Patricia LoRusso, Wells A. Messersmith, et al.. (2014). A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 73(5). 951–960. 61 indexed citations

Uppal, Hirdesh, Walter C. Darbonne, Daniela Bumbaca, et al.. (2014). Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1). Clinical Cancer Research. 21(1). 123–133. 150 indexed citations

Darbonne, Walter C., Daniela Bumbaca, B. Q. Shen, et al.. (2011). Abstract A135: T-DM1-induced thrombocytopenia results from impaired platelet production in a HER2-independent manner.. Molecular Cancer Therapeutics. 10(11_Supplement). A135–A135. 12 indexed citations

Culp, Patricia, Donghee Choi, Yongke Zhang, et al.. (2010). Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms. Clinical Cancer Research. 16(2). 497–508. 62 indexed citations

Polson, Andrew G., William Ho, & Vanitha Ramakrishnan. (2010). Investigational antibody-drug conjugates for hematological malignancies. Expert Opinion on Investigational Drugs. 20(1). 75–85. 60 indexed citations

Sawada, Kenjiro, Anirban Mitra, A. Reza Radjabi, et al.. (2008). Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target. Cancer Research. 68(7). 2329–2339. 303 indexed citations

Bhaskar, Vinay, Melvin Fox, Melanie Wong, et al.. (2007). Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits. Investigational New Drugs. 26(1). 7–12. 44 indexed citations

10.

Bhaskar, Vinay, Dong Zhang, Melvin Fox, et al.. (2007). A function blocking anti-mouse integrin α5β1 antibody inhibits angiogenesis and impedes tumor growth in vivo. Journal of Translational Medicine. 5(1). 61–61. 66 indexed citations

11.

Hollopeter, Gunther, Hans‐Michael Jantzen, D Vincent, et al.. (2001). Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 409(6817). 202–207. 1116 indexed citations breakdown →

12.

Smith, Rosealee, Alison L. Jenkins, Afrodite Lourbakos, et al.. (2000). Evidence for the activation of PAR‐2 by the sperm protease, acrosin: expression of the receptor on oocytes. FEBS Letters. 484(3). 285–290. 43 indexed citations

13.

Ramakrishnan, Vanitha, et al.. (1999). Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proceedings of the National Academy of Sciences. 96(23). 13336–13341. 74 indexed citations

14.

Law, Debbie A., Lisa Nannizzi‐Alaimo, Kyra J. Cowan, et al.. (1999). Signal Transduction Pathways for Mouse Platelet Membrane Adhesion Receptors. Thrombosis and Haemostasis. 82(8). 345–352. 5 indexed citations

15.

Giese, Neill A., Monique M.H. Marijianowski, Oscar McCook, et al.. (1999). The Role of Alpha and Beta Platelet-Derived Growth Factor Receptor in the Vascular Response to Injury in Nonhuman Primates. Arteriosclerosis Thrombosis and Vascular Biology. 19(4). 900–909. 68 indexed citations

16.

Kaufmann, Roland, et al.. (1998). Investigation of PAR-1-type thrombin receptors in rat glioma C6 cells with a novel monoclonal anti-PAR-1 antibody (Mab COR7-6H9). Journal of Neurocytology. 27(9). 661–666. 5 indexed citations

17.

Lokker, Nathalie A., JAMES P. OʼHARE, James Tomlinson, et al.. (1997). Functional Importance of Platelet-derived Growth Factor (PDGF) Receptor Extracellular Immunoglobulin-like Domains. Journal of Biological Chemistry. 272(52). 33037–33044. 46 indexed citations

18.

Nystedt, Sverker, Vanitha Ramakrishnan, & Johan Sundelin. (1996). The Proteinase-activated Receptor 2 Is Induced by Inflammatory Mediators in Human Endothelial Cells. Journal of Biological Chemistry. 271(25). 14910–14915. 313 indexed citations

19.

Ramakrishnan, Vanitha, et al.. (1993). A Novel Monoclonal Antibody Dependent on Domain 5 of the Platelet-Derived Growth Factor Beta Receptor Inhibits Ligand Binding and Receptor Activation. Growth Factors. 8(4). 253–265. 9 indexed citations

20.

Ramakrishnan, Vanitha & Ronald T. Borchardt. (1987). Adenosine dialdehyde and neplanocin A: Potent inhibitors of S-adenosylhomocysteine hydrolase in neuroblastoma N2a cells. Neurochemistry International. 10(4). 423–431. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact